In 2013, Shahim et al. [39] evaluated the role of different biomarkers (t-TAU, NfL, GFAP, and CSF:albumin ratio) in the CSF of children with epilepsy (including four with SE), different neurological conditions, and controls. This evidence concerns the gene GFAP and epilepsy.